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THE CHEMOTHERAPY OF PROTOZOAN 
AND BACTERIAL INFECTIONS 1 
DR. WALTER A. JACOBS 
The Rockefeller Institute for Medical Research 
T HE term Chemotherapy in its more restricted sense isemployed to designate that branch of investigation which 
deals with the discovery of chemical agents which act specifically 
on infectious diseases and with the study of their mode of 
action. The introduction of this term we owe to Ehrlich and 
the great progress which has been made in this field within 
the comparatively shor; space of two decades is due largely 
to the brilliant achievements and leadership of this worker. 1'he 
subject is now so vast that in the short time which is allotted 
to us we cannot do more than discuss certain phases of what 
has been learned. Our treatment of the subject must naturally 
fall into two divisions, that dealing with the chemotherapy of 
bacterial infections and finally, that in which animal parasites 
have been made the objective. We shall deal with the former 
first, since efforts to· iniluence experimental bacterial infections 
with chemical compounds antedate similar studies with . ani­
nral parasites. 
Not long after it became known that there are substances 
which would kill micro-organisms in the test tube, attempts were 
made to apply such germicides to disinfection within the organ­
ism. All of these expilriments postulated a direct action of 
the chemical upon the micro-organism ·within the host such as 
occurs in di-sinfection outside of the body. Among the very first 
investigations in this direction were tho e of Koch 1 who attempted 
to sterilize animals which h:ad been infected with anthrax bacillus 
by the use of bichloride of mercury. 
Although he was able to· inject this substance into the blood 
in such an amount as to achieve a concentration many times 
that which was necessary to kill the micro-organisms in vitro, all 
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the attempts proved fruitless. Koch attributed the discrepancy 
between the in vitro and in vivo results to the fact that mercuric 
chloride forms ·a chemical union with the serum proteins, as 
evidenced by the formation of a precipitate and was therefore 
rendered ineffective. 
In later work, particularly that of von Behring, we see numer­
ous other attempts to achieve internal disinfection. Occasionally 
indications were obtained ,vith the use of certain inorganic sub­
stances but such results proved of no practical value because 
of their great uncertainty and irregularity and the great toxicity 
for the animal shown by the amounts of chemical required. 
Although occasional effo.rts in this direction continued, this 
type of investigation came to be regarded as futile and almost 
impossible of achievement. We can see in the words of von 
Behring an expression of this gloomy outlook. After ten years 
of persistent attempts he finally concludes: 2 
'' It can be regarded almost as a law that the tissue cells 
of man and animal are many, times more susceptible to the 
poisonous effects of disinfectants than any bacteria known at 
present. Therefore, before the antiseptic has a chance either 
to kill or to inhibit the growth of the bacteria in the blood 
or in the organs of the body, the infected animal itself will 
be killed. The pessimism of him who declared that disinfection 
in the living body is for all time impossible appears to be only 
too justified. ' ' 
But with the more recent highly successful application of 
synthetic drugs to the treatment of protozoan diseases and 
because of the failure in so many instances of the more rational 
immunological methods, interest again centered in the possi­
bility of the therapeutic application of bactericidal agents. The 
problem has proven extremely difficult to appro'aeh by any other 
means. It has been particularly d�cult because of the lack 
of an empirical background such as had placed t}le qualities 
of arsenic, quinine and mercury at the disposal of the worker 
with protozoan infections. It has seemed to some that the 
only method short of the mere empirical testing of all sorts 
of" substances in the experimental animal was to employ the 
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bactericidal test at least '88 a means of initial orientation, even 
though it appear the crudest makeshift. 
The first extensive experiments in this direction were made 
by Bechhold JI and Ehrlich, who found in the group of halo­
genated phenols a number of substances which exhibited in vitro
a high order of inhibiting action on the growth, especially of 
the diphtheria bacillus. At }he same time it w-as possible to 
follow certain influences which chemical constitution seemed 
to exert on antiseptic action, such as the exalting effect, up to 
certain limit.a, of the multiplication of halogen groups or the 
addition of methyl groups to the molecule. But what is more 
important was the observation that none of these substances 
would sterilize laboratory animals infected with the diphtheria 
bacillus, "and this, in spite of the fact that the toxicity of some 
of the substances was low enough to permit the achievement 
of a concentration in the blood 100 times that required to kill 
this bacillus in the t.est tube. A possible explanation for this 
failure w.as again found in the greater affinity of these disin­
fectants for the blood proteins than for the bacteria. Although 
no visible precipitate was caused on mixing their solutions with 
serum, as in the c'ase of mercuric chloride, their bactericidal 
action in vitro was greatly redu.ced by the process. In this 
work we find for the first time the expression '' partial spe- . 
cificity "to designate a type of selective antiseptic action which 
a chemical may display towards a particular micro-organism. 
Compatibility with serum and partial specificity are factors 
upon which the subsequent workers with antiseptics have come 
to lay particular emphasis and their observations have fur­
nished us with not a few examples of the latter. In the tendency 
toward specificity was found a grain of hope, since it seemed 
a step in the right direction-in the direction of the specificity 
displayed by immunity principles. Marty instances of partial 
specificity .have been observed especially among the organic 
dyes. A number of these observations have been used as the 
basis of methods for the differentiation of bacteria in culture, 
such as that which employs gentian violet in media to restrain 
the growth of Gram-positive strains, or the use of brilliant green 
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to separate the typhoid from the colon bacillus. A study of the 
bactericidal properties of the quaternary salts of hexamethy­
lenetetramine 4, has brought out instances of substances which 
displayed a decided preference for the streptococcus. In not 
a few cases, substances were found which killed the streptococcus 
in dilutions which were 20-30 times greater than those required 
to sterilize suspensions of meningocooous and gonococcus. A 
most unusual example of specificity has come to light in the case 
of the toxicity of the alkaloid optochin for the pneumococcus, 
but to this we shall return later. Quite recently Browning, 
Cohen and Gulbransen/ have uncovered perhaps a still more 
remarkable instance in the case of the cyanine dye, sensitol red. 
'fhe lethal effect which it displays against staphylococcus is 2000 
times that which it exhibits against the colon bacillus in peptone 
water. I am, however, not aware of any experiments which have 
been performed with this substance in infected animals. 
In the quality of serum oompatibility we have presented to 
us in its simplest form the idea that a substance must display 
a greater affinity-for the micro-organism than for the tissues 
of the infected ·animal in order to be germicida
l
ly efficacious. 
But few substances have been found which retain their full 
activity in the presence of serum. A few favorable inst�nces 
have been observed among the juaternary salts of hexamethy­
lenetetra.mine which were prepared from certain chloracetyl­
amino compounds." A number of these exhibit a bactericidal 
effect in serum and protein solution which is very little less than 
that found in salt solutions, but their application to internal -dis­
infection was without result. Optochin maintains toward the 
pneumococcus a high degree of bactericidal efficiency in serum. 
'l'he low concentration of 1: 20,000 in serum and even that of 
1 : 8000 in oxalated blood have proved sufficient to kill this micro­
organism in 2 hours and in much higher dilutions it exhibits a 
definite growth restraining influence.o- However, tJ:iis is con­
siderably less than what is observed in ordinary salt solution, 
since in the latter medium a dilution of 1 to 500,000 or more 
is all that is required. Much more favorable relationships have 
been observed in the case of acridine compounds. Browning 
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and his co-work,ers 7 have found that diaminoacridine and it.s 
methochlorides, or proftavine and flavine respectively, actually 
exert a more potent action on the staphylococcus and colon bacil­
lus in serum than in ordinary saline. This very unique quality 
and the unusually potent b�ctericidal properties of these sub­
stances led to their application in the local treatment of wound 
infections. 
Still more difficult than to find substances which will resist 
the diverting inflmmce of serum constituent.a is to find antiseptics 
which will maintain a high bactericidal effect in blood. In 
experiments in our laboratories, Doctor Felton 8 m·ade a mnn­
ber of observations in regard to this point, and was able to 
find but few instances of substances which retain a high order 
of antiseptic poteney in this medium. Mention may be made 
of malachite green and a few of its derivatives and especially 
the flavines and certain dyes of the rosinduline group. The 
observed values were, however, lower than those shown in ordi­
nary saline. 
There are still other properties which may be considered 
among the desiderata for the ideal internal disinfectant. One 
of these is speed of bactericidal action. It has been very diffi­
cult indeed to find substances which act rapidly under the con­
ditions which obtain in the circulation. In order to kill the 
pneumococcus in 15 minutes, optochin must be used in a con­
centration of 1 :1000 in whole blood. Even.flavine in the same 
concentration fails to sterilize in one hour, although in two hours 
it may act in a dilution of 1 to 32,000. Taken alone, speed of 
action may not be essential, especially if a substance can be 
maintained sufficiently long in the cire1,tlation to develop slowly 
its action or to exercise merely a growth restraining or bac­
teriostatic effect. But here again we must postulate other con­
ditions fo order to obtain such a result. Repeated observations 
with optochin in animals and in man have shown that it is pos­
sible to render the blood antiseptic for pneumococcus but the 
observatio�s of Moore and Chesney 9 have shown that this may 
be complicated by the development of fastness. Browning and 
Gulbransen 10 h·ave demonstrated that the blood· of rabbits may 
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display a degree of inhibiting action for staphylococcus and 
the colon bacillus for several hours after the administration of 
diaminoacridine, but this alone was apparently inadequate. 
In the control of certain infectious processes the difficult 
requirements of proper distribution :and tissue penetrability of 
the antiseptic must be taken into consideration. In a former 
lecture before this Society, Lewis, in describing his experi­
mental studies on the chemotherapy of infections produced by 
the tubercle bacillus, has stressed the importance of combining 
in a substance a degree of germicidal action with specific tissue 
penetrating power. 
Finally, there is another group of requirements which must 
be discussed in connection with the in vivo operation of bac­
tericidal subst.ances. Not only must a substance be of sufficiently 
low general toxicity, b-ut it must prove comparatively harmless 
to the general powers of resistance and to the normal protective 
mechanism of the infected animal. In this connection we may 
have to deal with quite an extensive and perhaps less tangible 
group of factors which c:an be incorporated into systematic 
study only with the greatest difficulty. It may be just at this 
point that the real difficulty lies and we shall have occasion 
to refer to this later. 
In this connection, observations have been made to deter­
mine the effect on phagocytosis which might be exhibited by 
bactericidal substances. The e�eriments of Felton 8 have 
recently shown that not a few highly bactericidal dyes and 
cinchona derivatives markedly reduce the phagocytic index in 
dilutions ht which they might exhibit a bactericidal effect in 
blood. Exc.eptions in this regard may perhaps be the flavines, 
which, according to Browning, are not appreciably injurious 
in dilutions -above 1 :500. 
But if we consider in retrospect all of the conditions which 
may separate the observed in vitro properties of an antiseptic 
from its successful operation in an infected animal, it is apparent 
that we have presented a very difficult case for the idea that 
the control of bacterial infections m:ay be approached from 
the standpoint of internal disi�fectio�, This has certainly been 
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very generally borne out in attempts to apply such substances 
in actual infections. We shall later see that even in the more 
successful application of compounds to the control of protozoan 
infections, there have appeared repeated discrepancies between 
the action of substances on the parasite in th� test tube and 
in the animal. It would seem, therefore, that for the time at 
]east, we are thrown back on the empirical testing of substances 
in the infected animal as the only safe procedure. 
The first striking instance of the successful application of 
a chemical to the treatment of a bacterial infection in the labora­
tory animal we owe to the observations of Morgenroth and his co­
workers. Previous studies of Neufeld 11 and others had shown 
a certain biological similarity between trypanosomes, spirilla 
and the pneum-0coccus in the susceptibility of their 00.velopes 
to the dissolving action of bile salts. While engaged in a study 
of the effect of quinine derivatives in experimental trypanosome 
infections in small animals, Morgenroth and Halberstadter 12 
were able to demonstrate a certain curative effect of these sub­
stanc.es. Then partly beoouse of the possible biological similarity 
between the pneumococcus and the trypanosome and because 
of certain clinical observations on the applicability of quinine 
in the treatment of pneumonia, he was induced to make similar 
studies in experimental infections with the pneumococcus. 
Morgenroth and \ievy 18 found that a pneumococcus septi�emia 
induced in mice was but little affected by injections of quinine. 
On passing to hydroquinine, which differs from it by but two 
hydrogen atoms, a more definite influence was to be seen in 
delaying the death of the animals. An optimal effect, however, 
µ-reatly exceeding that of the former was furnished by ethyl­
hydrocupreine, or optochin, in which the methoxyl group of 
hydroquinine has been changed to ethoxyl. It was found p_ossi-
1:!le to save a good percentage of the infected animals by repeated 
injections particularly of a solution of the drug in oil. Unfor­
tunately the clinme.l application of the drug has been limited 
by its untoward toxic properties, especially the tendency to 
produce amblyopia. Moore and Chesney,9 from extensive observa­
tions on patients suffering from acute lobar pneumonia, have 
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concluded that the use of optochin · in the treatment of this 
condition cannot be recommended, since it is impossible to admin­
ister a sufficient amount to produce an effective concentration 
in the blood stream without exposing the patient to the danger 
of toxic effects. During the use of the necessarily subeffective 
doses the pneumooocci wiere observed even to become fast to 
the drug. 
It would appear that Morgenroth in his first experiments 
was unaware of the potent germicidal action of this substance 
on the pneumococcus, so that a knowledge of this property played 
no part in its initial chemotherapeutic application. We owe to 
Wright a the recognition of this quality as well as that of the 
fact that optochin kills the pneumococcus in high dilution in 
the presence of serum. The confirmation of these observations 
led Morgenroth to attribute the curative action of optochin. 
in the animal to its direct bactericidal effect and in his later 
studies he used the test tube as a guide. This later work 10 
developed the interesting influence which the chemical struc­
ture of the cinchona alkaloids exhibited on their specific anti­
septic action. 
On passing from quinine,· through hydroquinine to optochin, 
a sudden jump in the action upon the pneumococcus occurs 
to fall again on passing higher up the series of alkyl compounds. 
However, with the stage of the isoamyl ether a bactericidal effec­
tiveness towards streptococcus and staphylococcus becomes 
evident which is augmented on passing to the heptyl and isooctyl 
compounds and then drops again. These observations while inter­
esting in themselves had to do rather with ex�emal disinfection 
and proved inapplicable to the treatment of systemic infections. 
It would seem that the powerful bactericidal properties of 
optochin lend support to the belief that its curative effect in 
mice is a result of its direct bactericidal action. But certain 
observations of Neufeld and Engwer,16 and later by Moore,17 
have suggested the interposition of the host in the process. 
Moore found that a single small dose of optochin in oil which 
in itself was quite ineffective in the treatment of an experimental 
pneumococcus septicemia in the mouse, when combined in the 
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treatment with an amount of homologous anti-pneumococcus 
serum which was also far under the effective dose was capable 
of increasing the threshold value of this serum at least fifty 
times. 'l'his result indicates that the combined action of the 
two therapeutic agents was many times that of a simple summa­
tion of their protective effects. Whether a similar synergism 
or rather fortification occurs between the drug and certain unde­
termined protective factors when the drug is used a,lone in a 
so-called curative dose has not been definitely ascertained, but 
Moore's observations would seem to weaken somewhat the view 
that the bactericidal effect is the only factor-. 
Taking all that we have considered with reference to opto­
chin and its near relatives, as well as the ancient reputation 
which quinine has always had, we cannot escape the enticing 
suggestion that perhaps there is something inherent in the mole­
:cule of these alkaloids which, like the elements arsenic and 
mercury, has conferred upon them certain 1>otentialities as 
specific etiological remedies and that this property might be 
turned to wider usefulness if we could only find the way. 
A number of years ago we turned our attention to this prob­
lem in the laboratories of the Rockefeller Institute at the sug­
gestion of Doctor Flexner and also of Doctor Cole who was par­
ticularly interested in the possibility of finding new therapeutic 
agents for the treatment of infections produced by the pneumo­
coccus. In this work Doctor Heidelberger and I were extremely 
fortunate in the enjoyment of the skilful biological cooperation of 
Doctor W ollstein and later of Doctor Felton. 
The first problem was purely chemical. We have already 
seen what a pronounced change in biological properties has 
followed but slight chemical alterations in the quinine mole­
cule. W onld it be possible to find other means of altering the 
cinchona molecule in a systematic manner, but in a way to 
maintain its general integrity, and perhaps permit us to follow 
the influence of chemical modification on biological action f The 
naturally occurring members of the group, as we have seen, had 
been thoroughly studied and also their hydro-derivatives and 
the homologous ethers of hydroquinine as well. A successful solu-
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tion of the chemic.al problem was found by making use of the 
fact that these alkaloids as tertiary bases react with alk:ylhalides 
to form quaternary salts.18 In one direction in particular-by 
the use of chloroacetylamino compounds as alkylhalides it was 
possible to develop if necessary a practically unlimited number 
of new derivatives, and, in a way, to leave the original alkaloid 
molecule intact. Many substances were prepared into which a 
thorough selection of the usual organic groups had been intro­
duced. Then again a similar opportunity was offered in the 
preparation of a series of hydroxyazo dyes from hydrocupreine,19 
the phenolic compound obtained by demethylating hydroquinine. 
By coupling hydrocupreine with the diazonium salt of any aro­
matic amino compound it was possible to make a logical series 
of substances in which any chemical change could be featured 
at will. Still other series, 20 of a similar character were prepared, 
so that in ·a way it might be said that the opportunity of test­
ing the influence of chemical changes on the action of these 
alkaloids had been fairly completely presented. While realizing 
from all that was said before that the measure of bactericidal 
power was of doubtful importance, nevertheless, such studies 
were made because of their possible statistical value and since 
no other criterion short of the animal test was available. Within 
the groups of quaternary salts and a.zo dyes numerous instances 
of marked bactericidal power for the pneumococcus were noted 
and in several cases were found to equal even that of optochin. 
However, in the majority of instances, this activity was found 
to be greatly diminished in the presence of serum. I shall not 
burden you with an extensive account of these observations, but 
shall rather summarize the results obtained in the use of these 
substances in the experimental pneumococcus infection. Such 
tests made on substances, irrespective of bactericidal potency, 
showed a few which seemed to exp.ibit a small measure of thera­
peutic effect. The quaternary salts of hydroquinine with chlora­
cetyl-p-'aminophenol and chloracetyl-p-anisidine, in particular, 
if given not too long after inoculation of the mice or if not 
in too large amounts, often, though irregularly, ea.red the ani­
mals. An interesting and not infrequent observation which 
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waa made with these and similar substances was the effect of 
doses above a certain threshold, even though much under the 
lethal dose. In such cases, instead of the apparent cure observed 
with smaller doses, an actual acceleration of the disease was 
noted. An explanation of this curious paradox is perhaps not 
difficult to find, and may lie in the possibility that amounts of 
drug which are not frankly toxic may be sufficient to injure 
the animal's n·atural powers of resistance in such a way as to 
make it more susceptible to the infection. 
In this connection, we 
0
have made also a survtiy of the various 
groups of organic dyes in regard to their curative effect on 
pneu.mococcus infections in laboratory animals, but with similar 
unpromising results. Even flavine with its high bactericidal 
power in blood and serum for the pneu.mococcus gave but the 
slightest indication of influencing the infection. Observations 
made with quite a variety of other classes of substances were of 
a similar negative character. 
To sum up-while the experience of workers has brought 
to light not a few groups of bactericidal compounds, very few 
individual substances have displayed even a trace of specific 
therapeutic activity. These few substances have proved to 'be 
unique within the group to which they belonged, since closely 
related compounds, or those differing from the active substances 
by relatively insignificant chemical modifications have proved 
to be quite useless. I shall not keep you longer with this portion 
of the story except a word perhaps as to the general outlook for 
the chemotherapy of bacterial infections. At present the data 
available seem quite barren of suggestion. But I do not wish to 
imitate here quite the gloomy view which w&i quoted at the begin­
ning of this paper. The mere instance of optochin and of the 
therapeutic value of chaulmoogra oil and the more recently used 
esters of chaulmoogric and hydnocarpic acids obtained from this 
oil in the treatment of leprosy are indications that the control 
of bacterial infections by drugs is by no means impossible of 
achievement. The real difficulty lies in the necessarily oppor­
tunistic experimental method and the lack of a rational scientific 
means of approach. , The problem is essentially a search for a 
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substance of unknown nature but which must yet perform a ser­
vice by a mechanism of which we are equally uncertain. It may 
be possible to inquire successfully into what biological proper­
ties such a substance must possess, or under what biological con­
ditions it will have to �perate; but such information will not 
point to the substance itself. In the case of bacterial inf!)ctions, 
experience has presented us with too few points of contact be­
tween our knowledge of chemical structure and whatever biologi­
cal properties may be required in the exhibition of a therapeutic 
effect to present a rational basis for the search for curative 
substances. Perhaps the real solution of the problem may be 
ultimately found by gaining an insight into the chemical nature 
and mode of operation of the substances which are normally 
elaborated by the organism i:n its fight against infection. 
If we turn now to the appli�ation of chemical agents to the 
tre·atment of protozoan diseases, we are confronted by a far 
more encouraging state of affairs. We have already alluded 
to the traditional virtue of quinine and mercury and that these 
were purely empiri®-1 acquisitions. However, with the recogni­
tion of the etiological factors of the diseases which these sub­
stances influenced, the role which they occupied as real curative 
agents was likewise recognized. During the past twenty years 
considerably more has been added to our chemical equipment 
in the treatment of this group of , diseases as a result of the 
applic:ation of laboratory methods of both chemistry and biology. 
In the present paper I can, however, touch upon only certain 
phases of this development. The ·appearance in 1902 of the 
classical experiments of Laveran and Mesnil, 21 was the beginning. 
By the use of sodium arsenite these workers succeeded in tem­
porarily clearing the blood of mice infected with the parasite 
responsible for the disease of cattle called " Nagana." Then 
there followed within a few years· a succession of observations 
· in which substances belonging to a number of different groups
were found to possess a similar efficacy in experimental infec­
tions produced by the same or similar animal parasites. These
substances fall naturally into sever·al groups which it will serve
our. purpose best to treat separately. Soon after the observations
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of Laveran and Mesnil, Ehrlich and Shiga, 22 demonstrated that 
mice infected with trypanosoma equinum could be permanently 
cured by a single injection of trypan red, a tetrazo dye prepared 
by coupling tetrazotized benzidinesulfonic acid with a naphthyl­
aminedisulfonic acid. This is noteworthy as the first instance 
of the cure of an experimental trypanosome infection with a 
single dose of a synthetic chemical. However, the value of the 
substance itself seems to have been limit.e!l, since it failed to 
exert a similar therapeutic effect in other animals or with other 
types of trypanosomes. 
We meet here for the first time a peculiar paradox which 
was destined to appear repeatedly in later work. Although 
trypan red proved to be active in vivo, it was inactive in the 
test tube. At the time, these workers noted the staining of 
the tissues of the animal by the dye after injection. They 
consi_dered that its action was possibly due to the persistent 
effect of small amounts of the drug or of some active alteration 
product of it upon the parasites. The production of an activ:e 
immunity in the animal by the rapid destruction of the parasites 
by the drug wa8 considered also as a contributing factor. Obser­
vations of a similar character with other dyes became the basis 
for much subsequent discussion and inquiry as to the mechanism 
involved in the successful removal of trypanosome infections 
by such substances. In these discussions, which I cannot present 
at length, attempts were made to explain this paradoxical action 
also by the assumption of a direct injury produced by the dye 
on the trypanosome of a character which did not affect their 
motility but prevented their multiplication. The suggestion 
that a chemical alteration of these substances in the body to a 
more active form, while not so obviously applicable to this 
class of substances, has been more successfully applied, as we 
shall see, in explaining the action of arsenic compounds. Subse­
quently, Nicolle and Mesnil,23 found, from the study of a large 
number of similar substances, a benzidine dye trypan blue which 
proved still more efficacious in that it cured mice infected with 
the more resistant trypanosomes of Nagana and Surra. Dyes 
of all kinds were then investigated and, in succession, members 
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of the triphenylmethane group and a number of orthoquinoid 
dyes such as the pyronines, oxazines, thiazines and acridines 
were successfully brought into the field of investigation. But 
the practical application of the dyes, it would seem, has been 
on the whole rather restricted. The discovery of the therapeutic 
properties of the individual members of the different groups 
appears to have been for the most part the outcome of a rather 
opportunistic selection of substances. There have been attempts 
to correlate the therapeutic properties of some of them to their 
chemical constitution and to their selective staining property 
for the parasite. But, on the surface at least, it would seem 
that but few facts have emerged which could be applied to a 
systematic attempt at their further chemical development, or 
in explanation of whatever degree of therapeutic value they 
may have shown. 
An exception to this, perhaps, is the rather striking property 
which was found by Ehrlich and his associates to accompany 
t'he presence of the orthoquinoid structure of certain dyes. These 
dyes quickly produced tolerant or fast strains of trypanosomes 
which were also quite fast to arsenic. Paraquinoid dyes did 
not show this effect. Again Nicolle and Mesnil, 28 in a thorough 
survey of the tetrazobenzidine dye group concluded that in 
order to develop therapeutic qualities the coupler used must 
be a naphthalene derivative containing at least one amino group 
and two sulf onic acid groups. You will see from the chart that 
this condition is satisfied by both trypan red and trypan blue. 
And it is possible that this may have been made the starting 
point for the preparation of a substance known as Bayer-205, 
which has recently c:ome to offer considerable promise. The exact 
nature of this substance has been carefully withheld but there 
is a. suspicion that it belongs to a group of compounds which the 
Bayer Company patented some time ago.H I have on the chart 
formulm which suggest the possible relationship of this substance 
to tryp·an red and trypan blue. 
Preliminary observations of Handel and J oetten 23 and Mayer 
and Zeiss,28 have shown that this substance possesses remarkable 
curative properties in experimental trypanosomiasis. In small 
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doses which were often far below the toxic dose for the particular 
animal, the drug was found to cure the ordinary laboratory 
animals which had been infected with different strains of try­
panosomes. Here again we find the curiowi circumstances that 
the substance itself displayed no marked action on the trypano­
somes in vitro and microscopic studies seemed to suggest that 
the drug may act by preventing multiplication of the parasites. 
Later, therapeutic experiments in dourine in horses pointed 
to its usefulness as a prophylactic and curative agent but more 
important was its application to hum.an trypanosomiasis. We 
shall return to a discussion of this in another connection. Al­
though we can only infer the probable nature of this remedy, 
it would seem that an advance has been made by applying chemi­
cal knowledge to the problem of varying a group of substances 
which had already given indications of therapeutic values. Thus, 
the dyes from which this substance has emerged have come to 
share again, for the time at least, a prominence which was taken 
from them very early in chemotherapeutic studies by the advance 
in the application of arsenic compounds. 
If we turn now to the arsenic group we find that the organic 
arsenicals have proved a most profitable direction for the experi­
mental studies which led to the finding of synthetic etiological 
remedies. This is �ttributable in part to the fact that we are 
dealing with substances in which the therapeutic quality is appar­
ently inherent in the arsenic itself irrespective of the actual 
form or by what mechanism its action may come into play. This 
has made chemical reasoning simpler · in attempting to refer 
biological action to chemfo:al constitution, for it is far more diffi­
cult to interpret what should be the point of reference when a 
large organic molecule is consi�ered with regard to any inherent 
biological activity. 
The impetus to investigation in this direction c:ame with the 
report of Thomas, 27 that a proprietary arsenic preparation called 
atoxyl displayed a definite therapeutic effect in animals infected 
with different strains of trypanosomes. The rapid confirm·ation 
of this observa.t.ion soon led to its employment in African sleep-
G 
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ing sickness :and it has proved helpiul in the treatment of the 
early stages of this disease. 
But a step of the most far-reaching importance was Ehrlich's 
brilliant recognition of __ the true nature of atoxyl as the sodium 
salt of p-aminophenylarsonic acid or arsanilic acid.28 In analogy 
with sulfanilic acid, it is formed by the fusion of aniline with 
arsenic acid. In its essentials, the chemistry of organic arsenic 
compounds had been pretty thoroughly studied by Michaelis and 
his co-workers, but the methods at the disposal of these chemists 
were, in a sense, limited. The discovery that arsenic could be 
introduced into the molecule by direct arsenation opened to 
Ehrlich and his associates a means for a most thorough develop­
ment of the chemistry of this group of substances. The immediate 
suggestion which the structure of p-aminophenylarsonic acid 
presented was detoxification by acetylation of the amino group. 
But the resulting product arsacetin, though possessed of a degree 
of therapeutic power, was soon discarded because in i,ts c.linical 
application, like· atoxyl, it not infrequently produced blindness 
and other toxic manifestations. Here again the peculiar paradox 
apI.iears that the pentavalent compounds are without appreciable 
action on the trypanosomes in vitro. But Ehrlich's 29 fertile 
imagination soon found a possible solution for this discrepancy. 
'
l
'he fact was noted that individual animals treated with certain 
pentavalent compounds would show a varying tolerance for 
the drug and those which exhibited the lower tolerance could 
be cured by smaller doses. This observation was coupled with 
the well known ability of the tissues to exhibi� a reducing action 
and with the fact that certain trivalent forms of arsenic are 
far more toxic than the pentavalent forms. Ehrlich concluded 
that the pentavalent arsenicals are reduced by the tissues and 
unfold their activity in the trivalent form. This view was sup­
ported by the direct comparison of the relative toxicities of the 
three stages of oxidation of arsanilic acid, p-aminophenylar­
sinoxide is 75 times more toxic for the mouse than arsanilic 
acid, while the arseno compound is 30 times more toxic., Similar 
toxicity relationships have been repeatedly observed. 
But more important still is the contrast in the trypanocidal 
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effect of the oxide and the arsonic acid in vitro. In a dilution of 
1 :100,000 the !ormer kills the microorganisms immediately, 
whereas atoxyl fails to act even in a 5 per cent. solution. In
some cases the arseno-�ompounds have shown a similar potent 
action in the test tube but this has not always appeared. Men­
tion may be made of observations of the failure of salvarsan to 
act directly upon the relapsing fever organism so or on the 
treponema pallidum in the test tube although the organisms 
thus treated were observed to lose appreciably in virulence as 
shown by subsequent injection into animal... Ehrlich and 
Roehl 81 placed particular emphasis on the oxide stage which 
may be formed either by reduction of the pentavalent compound 
or by oxidation of the arseno-derivative as the form in which 
the biological manifestations eventually appear. It is perhaps 
important to mention this point, since recent statements have 
appeared which seem to overlook this fact.; 
The conception of the biological potency of trivalent arsenic 
was at once applied to further synthetic attempts to· find new 
curative ,agents in the arsenic group. The great toxicity of 
the arsenoxides, however, and the possibilities which the arseno 
r..ompounds came to afford was the reason for the main interest 
which seemed to attach to the latter group. This work, as you 
all know, culminated in the brilliant discovery of the value of 
salvarsan and its derivatives in the treatment of certain spiro­
chrete diseases. 
In his theoretical considerations to explain the action of 
chemotherapeutic agents, Ehrlich assumed a direct action of 
the substance or its alteration product on the parasites. He 
conceived this action as being brought about by the avidity of 
certain groups or chemoceptors in the cell of the parasite for 
certain groups contained in the che:miic:al. By assuming these 
discrete affinities within the cell the attempt :was made to give 
more visible expression to certain phenomena which were ob­
served in the reaction of microorganisms to chemicals containing 
certain groups in the molecule. But, on the whole, workers no 
longer agree that such precise definition can be given to the 
relationship between chemical constitution and therapeutic action. 
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The efficacy of salvarsan was attributed in part to its orth­
aminophenol group which was supposed to direct the drug at 
the parasite in a way to permit the lethal action of the arsenic 
to develop. The analogy was drawn with trypan blue which 
likewise possesses an amino and hydroxyl group in positions 
ortho to one another. But there are many cases where such 
analogies do not hold. It is said, for instance, that the isomers 
of salvarsan containing this configuration are all much less 
active than salvarsan itself. Again particular stress has been 
laid on the dystherapeutic effect of the methyl group but num­
erous instances have arisen in which substances containing the 
methyl group have actually exceeded in effectiveness the unmethy­
lated com.pound. In this respect, trypaflavine is more efficacious 
as a trypanocide than the unmethylated proflavine. Quinine, 
which is methyloxycinchonidine is more efficacious in malaria than 
cinchonidine or the phenol, cupreine. The sulfuric group is 
still another well ·known example. In ma.ny combinations it 
may destroy therapeutic efficiency. Morphine or quinine when 
oonverted into the sulfuric esters, although again easily recover­
able by saponification, are physiologically practically inert. On 
the other hand, several sulfuric acid radicals are contained in 
· the molecule of trypan red, trypan blue and probably Bayer-205.
The conclusion is forced, therefore, that we may attribute only
the bare possibility of certain effects to certain groups in the
molecule and in any event, the molecule as a whole certainly
must be considered.
But the striking changes in biologic:al properties that often
follow very minute changes in structure and the occasional
appearance of regularity of biological response to such cha:nges
have always been a fascination and a source of tem'ptation to
the worker to try to utilize such general tendencies in the synthe­
sis of drugs. Several years ago, a group of us at the Rockefeller
Institute, Doctors Brown and Pearce and Heidelberger and
myself were tempted to take up a phase of this question. In
this work the attempt was made to obtain some information
from a systematic biological study of the toxic and therapeutic
properties of certain typ� of arsenic comppunds which might
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be applied to the finding of new remedies. 'l'his work which 
at first embraced a study of the treatment of experimental try­
panosomiasis was later extended to include that of the experi­
mental infections produced by the relapsing lever organism and 
experimental syphilis in the rabbit. 
We have already described the emphasis which has been 
placed on trivalent aisenicals. Since the biological activity was 
an exhibition of a property of some form of trivalent arsenic, it 
was undoubtedly a logical step, if considered alone, to use this 
group of compounds directly. But we may regard this question 
from another angle. There seems fair evidence at hand that the 
greater tolerance for pentavalent arsenioals as a group is not 
alone a function of their greater biological inertness as com­
pared with the trivalent-compounds but also to the speed with 
which the greater portion is excreted before the reducing action 
of the tissues c:an manifest itself. This is but a manifestation 
of the fact that the arsonic acids which form neutral salts 
possess a relatively greater portability in the blood stream and 
body :fluids than the trivalent forms as well as a greater pene­
trability and may readily and quickly diffuse through the tissues. 
The arsenoxides possess this to a much less degree and because 
of their degree of unsaturation are chemically very reactive 
and while perhaps initially portable, readily become bound by 
and denaturize such functional or tissue elements as may be deter­
mined by the general character of their molecule before the same 
degree of distribution can be achieved. This rapid fixation finds 
expression in the .rapid exhibition of potent toxic manifestations. 
The arseno compounds as a group possess double the molecular 
weight and, although perhaps also quite reactive, are the least 
readily transported ·and the least diffusible of all. Where there 
is no special acid salt forming group, substances of this class 
may be held in solution for a short time only, aided perhaps 
by the protective serum colloids, but may be readily deposited 
as such along the route before complete distribution is possible 
and then more slowly unfold their toxic effects through oxida­
tion to the oxides. • If we were dealing with an. infection which 
is confined to the blood stream alone it would seem, therefore, 
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admissible to place reliance upon the direct quick action of the 
trivalent compounds and the simple formula of the ratio of 
parasitotropic to organotropic properties of a substance. But 
when the more usual ti�ue infection is· to be influenced the 
question of distribution and diffusibility becomes a very import­
ant factor to consider. It is quite conceivable that certain advan­
tages in this regard may result by the use of the pentavalent 
form which may compensate for what it may seem to lose in 
immediate direct parasiticidal properties. By more complete 
distribution and tissue penetration it might be possible to reach 
localities which m:ay harbor such residues of an infection as 
may again become generally active. In such localities the reduc­
ing action of the tissues may supply a small but sufficient amount 
of therapeutically active material. 
In spite of Ehrlich's somewhat orthodox adherence to the 
trivalent idea we can see evidence of his occ:asional return to 
the pentavalent compounds. In his Schlussbetrachtungen,80 the 
possibility is pointed out of the applicability of hydroxyamino­
phenylarsonic acid, the pentavalent stage of salvarsan, for local 
therapy where the arseno compound circulating in the blood 
cannot reach the affected tissues in sufficient amount, as, for 
instance, in local eye involvement. Hata 's experiments showed 
severai pentavalent compounds to exhibit a good ratio of cura­
tive to toxic action but we obtain the impression that these 
workers were perhaps prejudiced against the group because �f 
a neurotropic tendency which a number of these substances 
displayed. This exhibited itself in the development of incoor­
dina,tion in the so-called '' dancing-mice.'' 
Considerations of a practical character have arisen in connec­
tion with the arseno compounds caused by certain inherent 
difficulties which are associated with their chemic-al and physical 
properties. They are unsaturated, highly reactive substances. 
Slight modifications in the method or conditions of preparation 
may have a great influence on their general toxic and also thera­
peutic behavior. It is not possible to obviate this readily by 
the subsequent use of the ordinary methods of pul;'ification such 
as recrystallization but very careful control of preparative con-
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ditions is required which can be only empirically ascertained. 
It has been necessary, therefore, to maintain a constant biological 
control of those substances of the group which are clinieally 
employed. Further, the development of this class of substances 
is in a sense limited because the arseno compounds depend for 
solubility on the presence of salt-forming 1 groups. The pentava­
lent compounds possess much more favorable chemical and physi­
cal properti�. The arsonic acids as a rule are perfectly stable, 
crystalline compounds which can be readily purified. They 
form· stable salts and therefore do not require the presence of 
other salt-forming groups for solubility. 
It appeared to us, therefore, that the development of penta­
valent compounds was certainly worthy of further trial. In 
the selection of the chemical material for our studies such groups 
of substances were chosen �hich would combine a sufficient 
degroo of accessibility with the opportunity for ample and logical 
chemical development in such direction as the biological result 
might indicate. From this material .it was hoped to accumulate 
statistical data regarding the influence of chemical constitution 
on biological act'ion which could be utilized in further work. 
An idea of the chemistry. of these groups of substances is best 
obtained by reference to the chart. 82 The studies were not alone 
confined to the pentavalent group but in certain instances where 
the presence _of a solubilizing group would permit, reduction to 
the trivalent stage was tried to test the value of such a chemical 
transformation. 
Over 230 substances were prepared. Their action as regards 
toxicity and therapeutic properties in one or more laboratory 
animals infected with the different animal parasites was studied. 
The observations were too extensive to attempt t._o do .more here 
than very briefly and superficially summarize the results. Sub­
stances were observed which varied all the way from those posses­
sing a very high toxic.ity to such which were easily tolerated 
and at the same time exhibited varying degrees of therapeutic 
power. But the observations with these substances brought out 
the fact that in the biological measure of each compound so 
many different factors had to be considered that it became ex-
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tremely difficult to find any sharp· regularities with regard to the 
influence of structure on action. But in some cases, it was possi­
ble to note a. few very general tendencies which were utilized 
to advantage in the work. 
., 
The most important group and that which was most fully 
studied was that of the amide and substituted amides of phenyl­
glycine-p,-arsoni:c acid:. This type of compound was chosen 
partly for the reason that the ·glycine amide NHCH2CONH group 
not only offered an excellent chance to add practically any chemi­
cal group to the molecule which was desired, but because the 
glycine amide group itself is a norm•al constituent of proteins and 
should be inherently compatible. These substances were in gen­
eral prepared by the interaction of the amino group in arsanilic 
acid or its analogues with chloroacetyl derivatives of amines in 
which members of both the aliphatic and aromatic series were 
· given ample representation. Changes in both therapeutic and
toxic effects were observed in response to chemical alterations
in the molecule often of a decided character which depended
not only upon the animal used but also the type of infecting
0rganism. Only in certain instances was it possible to fol­
low any general tendencies. To begin with, the parent sub­
stance, phenylglycine-p-arsonic Mid, we have met a near relative
before in the form of arsenophenylglycine, which is obtained
from the arsonic acid by reduction. Contrary, however, to
the potent therapeutic properties exhibited by arsenophenyl­
glycine in experimental trypanosomiasis, the pentavalent form,
while it can be tolerated by laboratory animals in large amounts,
is practically devoid of therapeutic effect. In this series, as
far as it was carried, the ca'rboxyl group, while acting fairly
constantly as a detoxifying influence, was found to possess a
dystherapeutic effect. This was at variance with instances
noted in other groups of compounds and like all such irregu­
larities, which have made prediction impossible, there is no
explanation at hand. · In general, it has become evident that
the tendencies which are observed in the apparent influence
of constitution on biological action are confined pretty nar­
rowly to substances which are built on the same general pla.n.
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On passing to the amide or ureides of the compounds contain­
ing these carboxyl groups, no matter where they were situated 
in the molecule, there was in general an appearance iof thera� 
peutic effect in spite of a tendency to increased toxicity. This 
therapeutic effect of course varied greatly with the particular 
compound, the animal and the infection used. A number of 
substances of the series from the biological standpoint proved 
to be of outstanding interest. In an extensive series of biological 
tests, Doctors Brown and Pearce 83 definitely established that 
one of these in particular possesses unusually favorable biologi­
cal properties. This substance, the sodium salt of phenylgly­
einamide-p-arsonic acid, or tryparsamide, as it has since been 
named, has now come to be of definite, practical, therapeutic 
importance. 
Tryparsamide is a white, crystalline, stable substance which 
is extremely soluble in water with the formation of a practically 
neutral solution and is very easily prepared by the interaction 
of sodium arsanilate and chloroacetamide. As regards the bio­
logical properties of this substance, I cannot do better than 
quote from Doctor Pearce a sort of summary : 34 
'' Toxicological experiments demonstrated that the reaction 
of different species of laboratory animals to the drug was of 
n favorable character. The substance lends itself well to almost 
any method of administration and can be given to animals in 
large doses and the toxic effects were confined to doses relatively 
close to the minimum lethal dose. The recovery of animals from 
sublethal intoxication was remarkably rapid and complete, thus 
making possible the repetition of large doses at comparatively 
short intervals of time. The therapeutic activity of the drug 
in experimental trypanosomiasis was particularly evidenced by 
the relative speed and sharpness of action in the acute blood 
infections of mice and rats and by the potency and duration of 
action in the subacute and chronic tissue infections of guinea 
pigs and rabbits. The accomplishment of a permanent cure was 
obtained in the experimental infections proauced by five strains 
of pathogenic trypanosomes. Tr. brucei, Tr. gambiense, Tr.
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evansi, Tr. equiperdum and Tr. equinum. Comparative experi­
ments in laboratory animals with drugs which had been previously 
used, such as atoxyl, arsacetin, arsenophenylglycine, and the sal­
varsan derivatives, all of which had been previously used in the 
treatment of human trypanosomiasis, showed that tryparsamide 
was in many respects superior.'' 
In her clinical observations made in the Belgian Congo several 
years ago, Doctor Pe.arce,8' was able to substantiate the favorable 
indications which the experimental results with tryparsamide 
had given. It was shown that the drug was well tolerated and 
gives rise to no untoward symlptoms except an occasional ten­
dency, following too intensive a use of the drug, to produce 
visual disturbance in certain advanced cases. This, however, 
was usually transitory. The therapeutic results obtained in the 
preliminary use of the drug in 77 cases of sleeping sickness pro­
duced by Trypanosoma gambiense were very encouraging. More 
recently, Doctor Chesterman 35 in the Belgian Congo has defi­
nitely confirmed Doctor Pearce's general observations. From 
observations on the intravenous use of the drug he concludes 
that the maximum tolerated dose (which he believes should not 
exceed 4 grams per week for the full-sized adult) if given 
regularly for a period of about eight weeks is capable of com­
pletely removing trypanosomes from and rendering normal, the 
cell content of the cerebrospinal fluid of even the most advanced 
cases. This change is accompanied by a very marked clinical 
improvement which was observed to persist for practically a 
year, which was the longest time which had elapsed since his 
last use of the drug. Improvement was 'hardly less marked 
in cases which had resisted previous treatment with the drugs 
such as atoxyl. By a careful check on the patient it was possi­
ble to avoid the danger of any aP.Preciable degree of visual 
disturbance. Up to the present, we see no reason to change our 
estimates of the value of the drug. 
Doctor Smillie 80 has recently had the opportunity to extend 
the studies with tryparsamide in another direction, to the treat­
ment of mal de cad.eras which has become one of the biggest eco-
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nomic. problems of the vast Paraguay Valley in South America, 
since this disease is causing the yearly loss of thousands of 
horses. In a preliminary communication he reports that the 
drug has been found to be definitely efficacious in the treat­
ment of the early stages of the disease when the blood of the 
horse or mule is swarming with trypanosomes. This stage is 
from all practical considerations of the greatest importance 
to control. 
But to return to human trypanosomiasis, it is seen that the 
two main directions which chemical efforts have taken to pro-·, 
duce remedies for this disease have almost simultaneously yielded 
results which now give a more encouraging outlook with regard 
to its control-on the one hand, Bayer-205, most probably closely 
related to the benzidine dye group, and tryparsamide, a penta­
valent arsenic compound. At the present time, it is perhaps 
too early to compare the relative efficacy of Bayer-205 and trypar­
sam.ide. There have been reports already with regard to Bayer-
205 which indicate that the drug, although of definite value as 
a prophylactic, or i.in the early stages of the disease, has failed 
to give results in the more advanced cases. Tryparsamide, ou the 
other hand, as Pearce and Chesterman have shown, has been 
the cause of definite improvement in patients even in the more 
advanced stages of the disease. Bayer-205 has been reported 
to exhibit a definite toxic behavior from which the patients 
or animals only slowly recover. This takes the form occasiop­
ally of an albuminuria. A general tonic effect has characterfa.zed 
the behavior of tryparsamide and perhaps the only untoward 
action has been the occasional visual disturbance which has 
been noted to follow., too intensive a use of the drug. But, as 
before stated, this is in most cases of a temporary character. 
We shall perhaps have to wait a number of years before these 
drugs will have reached their final evaluation. 
There is a temptation perhaps to speculate with regard to 
the chance that the more successful of the arseniool remedies 
which have been used for the treatment of human trypano­
somiasis have been pentavalent compounds. In the case of 
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trypari:,amide, there seems every reason to attribute itc;; efficacy, 
'T not only to its powerful stimulating action on the animal economy 
and on the animal resistance, but to its great tissue penetrability 
and to its affinity for the tissues of the central nervous system 
which are involved in the more advanced stages of the human 
disease. This property has been demonstrated again in the 
behavior of the drug in certain types of neurosyphilis. In neuro­
syphilis ther� is a distribution of organisms in the central nervous 
system which is1 in a sense, comparable to that which occurs in 
trypanosomiasis. This has in the past suggested the possibility 
that perhaps even at the time when the etiological relationship of 
paresis to syphilis was merely suspected, drugs which have proved 
efficacious in the treatment of human trypanosomiasis might find 
a usefulness in the treatment of paresis. Years ago, atoxyl, for 
instance, was repeatedly tried in this connection, but in all 
these attempts, it has proved quite inadequate. It was, however, 
a natural thought to consider tryparsamide in this connection, 
although its treponemacidal properties are not very marked. 
Nevertheless, in experiments in rabbits . it had been shown to 
possess a marked action on the experimental lesions produced by 
the spirochetes. This was evidenced by their complete resolution 
and healing even in the presence of actively motile spirochetes 
which seemed to show little or no tendency to cause a recurrence. 
A few years ago, Doctors Lorenz, :Jjoevenhart, Bleckwenn, 
and Hodges,37 in order to test the applicability of tryparsamide 
in this connection undertook a series of observations on a group 
of patients afflicted with paresis. They have concluded that 
tryparsamide on intravenous injection is definitely efficacious 
in the treatment of early paresis and certain other forms of neuro­
syphilis. Later observations have essentially confirmed this. 
It is perhaps too early to make a more precise statement with 
regard to the clinical use in all , of its phases of tryparsamide 
in this disease, but sufficient is already known to demonstrate 
that it should have a field of usefulness in �ertain conditions 
for which there has been, heretofore, no efficacious mode of 
treatment. 
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If time would permit, still other phases of the progress which 
bas been made in the application of chemical agents to the 
specific treatment of infectious diseases might be reviewed. But 
sufficient has been brought before you tonight to show .that the 
results achieved have been far in excess of what was needed 
to justify the initiation of this type of investigation. In no 
sense, however, can any result such as the arsphenamines, Bayer-
205 or tryparsamide be considered the sU.IIlllilit of possible attain­
ment and there is every reason to expect the ultimate discovery 
of more powerful agents. And as time goes on, new groups 
of substances and an ever-widening field for their therapeutic 
application may well be expected. There is perhaps no more 
hopeful direction for the continuation of effort. But those who 
engage in such undertaking must carry with them a certain 
measure of opportunism., since in spite of the constantly in­
creasing number of positive observations, there is still lacking 
a general theory as to the chemical and physical factors which 
underlie specific therapeutic action. In this respect we are 
perhaps less informed than in the case of certain rules which 
seem to govern pharmacodynamic action. But I think that it is 
in this direction that further effort is required. We should not 
alone strive for the attainment of practical results, but continued 
attempts should be made to ascertain all of the theoretical factors 
which may contribute to chemotherapeutic action. 
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